Cidara Therapeutics, Inc.
New Filing
CIK: 0001610618·Biotechnology·DELAWARE·Filed: Oct 31, 2017
Total Offering
$20,160,000
Amount Sold
$20,160,000
Investors
16
First Sale
Oct 24, 2017
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2012
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Jeffrey Stein | Related Person |
| Kevin Forrest | Related Person |
| Daniel D. Burgess | Related Person |
| Scott M Rocklage | Related Person |
| Theodore R. Schroeder | Related Person |
| Robert J Perez | Related Person |
| Timothy R Franson | Related Person |
| Matthew Onaitis | Related Person |
| Taylor Sandison | Related Person |
| Ken Bartizal | Related Person |
| Paul Daruwala | Related Person |
| Neil Abdollahian | Related Person |
Company
SEC Filing
0001610618-17-000053
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free